NCT06120335

Brief Summary

The goal of this observational study is to develop a scale for cancer patients' willingness to voluntarily participate in drug clinical trials and evaluate its reliability and validity.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Nov 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 2, 2023

Completed
5 days until next milestone

First Posted

Study publicly available on registry

November 7, 2023

Completed
2 days until next milestone

Study Start

First participant enrolled

November 9, 2023

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2024

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2024

Completed
Last Updated

January 24, 2024

Status Verified

January 1, 2024

Enrollment Period

7 months

First QC Date

November 2, 2023

Last Update Submit

January 22, 2024

Conditions

Cancer

Keywords

drug clinical trialscancer patientswillingness

Outcome Measures

Primary Outcomes (1)

  • A semi-structured interview

    A semi-structured interview is conducted to investigate the willingness of cancer patients to participate in drug clinical trials and its influencing factors. The researcher will analyze the interview results and summarize several themes that reflect the willingness.

    3 months

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult tumor patients treated at Sun Yat sen Memorial Hospital at Sun Yat sen University

You may qualify if:

  • Age 18-80 years old (including boundary values).
  • Tumor patients with clear diagnosis.
  • Whether they finally sign the informed consent form of one drug clinical trial or not, and whether they are finally enrolled in one drug clinical trial or not, patients who have undergone the informed consent process of drug clinical trials conducted by clinicians can be enrolled in this study.
  • Volunteer to participate in this study and sign an informed consent form.

You may not qualify if:

  • Patients with unclear consciousness.
  • Patients who are unable to correctly understand and answer questions.
  • Vulnerable subjects include: students and subordinates of researchers, military personnel, prisoners, patients with incurable diseases, patients in critical situations, those admitted to welfare institutions, homeless individuals, minors, and those who are unable to provide informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sun Yat-sen Memorial Hospital

Guangzhou, Guangdong, 510000, China

RECRUITING

MeSH Terms

Conditions

Neoplasms

Central Study Contacts

Caie Chen

CONTACT

18707657343chence3@mail2.sysu.edu.cn

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
OTHER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 2, 2023

First Posted

November 7, 2023

Study Start

November 9, 2023

Primary Completion

June 1, 2024

Study Completion

September 1, 2024

Last Updated

January 24, 2024

Record last verified: 2024-01

Locations

CN(1)